Exploiting ROS and metabolic differences to selectively killing cisplatin resistant lung cancer

被引：0
|
作者：
Wangpaichitr, Medhi
Wu, Chunjing
Li, Ying Ying
Shah, Sumedh
Chen, Shu-Mei
Dinh, Vy
Kuo, Macus T.
Feun, Lynn G.
Savaraj, Niramol
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1038
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
    Wangpaichitr, Medhi
    Wu, Chunjing
    Li, Ying Ying
    Nguyen, Dan J. M.
    Kandemir, Hande
    Shah, Sumedh
    Chen, Shumei
    Feun, Lynn G.
    Prince, Jeffrey S.
    Kuo, Macus T.
    Savaraj, Niramol
    ONCOTARGET, 2017, 8 (30) : 49275 - 49292
  • [2] The emerging role of thioredoxin-1 on ROS and metabolic reprogramming in cisplatin resistant lung cancer
    Wangpaichitr, Medhi
    Theodoropoulos, George
    Wu, Chunjin
    You, Min
    Feun, Lynn G.
    Kuo, Macus T.
    Lampidis, Theodore J.
    Sayaraj, Niramol
    CANCER RESEARCH, 2012, 72
  • [3] Targeting metabolic alteration in cisplatin-resistant lung cancer
    Wangpaichitr, Medhi
    Wu, Chunjing
    Li, Ying Ying
    Chen, Shumei
    You, Min
    Vy Dinh
    Feun, Lynn G.
    Kuo, Macus T.
    Savaraj, Niramol
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Aberrant ROS Served as an Acquired Vulnerability of Cisplatin-Resistant Lung Cancer
    Xin, Qian
    Ji, Qinghong
    Zhang, Ying
    Ma, Weihong
    Tian, Baoqing
    Liu, Yanli
    Chen, Yunsong
    Wang, Fei
    Zhang, Ran
    Wang, Xingwu
    Yuan, Jupeng
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [5] Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells
    Tuerk, Dora
    Hall, Matthew D.
    Chu, Benjamin F.
    Ludwig, Joseph A.
    Fales, Henry M.
    Gottesman, Michael M.
    Szakacs, Gergely
    CANCER RESEARCH, 2009, 69 (21) : 8293 - 8301
  • [6] "Metabolic Reprogramming" in Ovarian Cancer Cells Resistant to Cisplatin
    Montopoli, M.
    Bellanda, M.
    Lonardoni, F.
    Ragazzi, E.
    Dorigo, P.
    Froldi, G.
    Mammi, S.
    Caparrotta, L.
    CURRENT CANCER DRUG TARGETS, 2011, 11 (02) : 226 - 235
  • [7] Synergistic killing of lung cancer cells by cisplatin and radiation via autophagy and apoptosis
    Liu, Min
    Ma, Shumei
    Liu, Mingbo
    Hou, Yufei
    Liang, Bing
    Su, Xu
    Liu, Xiaodong
    ONCOLOGY LETTERS, 2014, 7 (06) : 1903 - 1910
  • [8] Mitochondria-Targeted Multifunctional Nanoprodrugs by Inhibiting Metabolic Reprogramming for Combating Cisplatin-Resistant Lung Cancer
    Lu, Haibin
    Tong, Weifang
    Jiang, Meixu
    Liu, Huimin
    Meng, Chen
    Wang, Kai
    Mu, Xupeng
    ACS NANO, 2024, 18 (32) : 21156 - 21170
  • [9] The role of DNA repair pathways in cisplatin resistant lung cancer
    O'Grady, Shane
    Finn, Stephen P.
    Cuffe, Sinead
    Richard, Derek J.
    O'Byrne, Kenneth J.
    Barr, Martin P.
    CANCER TREATMENT REVIEWS, 2014, 40 (10) : 1161 - 1170
  • [10] Metabolic inhibitors that enhance cisplatin sensitivity in lung cancer cells
    Okamoto, Yuka
    Tomida, Akihiro
    CANCER SCIENCE, 2021, 112 : 385 - 385
12345